BC Week In Review | May 24, 2010
Clinical News

Amvisc regulatory update

Anika said FDA accepted its corrective actions designed to resolve manufacturing problems raised in a 2008 Warning Letter related to observations made by the agency during a visit of Anika's manufacturing facility in Woburn, Mass....
BC Week In Review | Jun 17, 1996
Company News

Chiron, Lifecore deal

CHIR's Chiron Vision exercised an exclusivity clause in its ophthalmic hyaluronate supply agreement with LCBM. LCBM previously supplied Amvisc and Amvisc Plus Ophthalmic Solution to CHIR under a non-exclusive agreement. LCBM now may not offer...
BC Week In Review | Aug 21, 1995
Clinical News

Chiron, Lifecore regulatory update

LCBM (Chaska, Minn.) received an initial undisclosed purchase order from CHIR's Chiron Vision unit for AMVISC and AMVISC PLUS viscoelastic ophthalmic solutions manufactured from LCBM's sodium hyaluronate. The order calls for European shipments to begin...
BioCentury | Mar 13, 1995
Strategy

Ophthalmics

Chiron as consolidator Chiron as consolidator Ophthalmics Ophthalmics Chiron Corp. 's $95 million move to combine its Chiron Vision business with the ophthalmic surgical division of Iolab aims to create a deep product line capable...
BC Week In Review | Dec 12, 1994
Company News

Lifecore deal

Lifecore Biomedical Inc. (LCBM)   The Chaska, Minn., company finalized its previously announced agreement with Johnson & Johnson 's IOLAB Corp. subsidiary. LCBM will supply sodium hyaluronate powder and pre-filled sterile syringes for IOLAB's Amvisc...
BC Week In Review | Apr 18, 1994
Company News

Lifecore deal

Lifecore Biomedical Inc. (LIFC)   The Chaska, Minn., company signed a letter of understanding with Johnson & Johnson 's Iolab Corp. subsidiary, under which LIFC will supply Iolab with ophthalmic sodium hyaluronate for Iolab's Amvisc...
Items per page:
1 - 6 of 6